7 Pulmonary Fibrosis Headlines You Can’t Miss


3. IPF Patients on Pirfenidone Who Seriously Decline Should Stay on Treatment, Study Advises

ipf pirfenidone

Clinicians managing people with idiopathic pulmonary fibrosis (IPF) are left with few options once the disease seriously progresses, despite pirfenidone treatment. Now a study shows that continuing treatment is the best way to move forward, as it is likely to prevent an even greater decline in lung function and improve life expectancy.

Read more about it: http://bit.ly/21z13Ux

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *